Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics

directed medical countermeasure initiative. HEALER seeks to develop a diverse portfolio of threat agnostic, host-directed therapeutics that enhance the body�s ability to withstand, mitigate, and recover from the complex physiological impacts of CBRN threats. Because the underlying pathophysiology o

f injury following CBRN exposure and civilian critical care challenges are often governed by convergent host response mechanisms, this program creates a viable commercial opportunity that exceeds the traditional CBRN mission space. This ini